|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 7/26/16 Philip Morris International Inc. 10-Q 6/30/16 93:10M |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 1.17M
2: EX-4.1 Deed of Termination and Release of Euro Medium HTML 57K
Term Note Programme
3: EX-12 Statement Regarding Computation of Ratios of HTML 49K
Earnings to Fixed Charges
4: EX-18 Preferablility Letter HTML 33K
5: EX-31.1 Certification of CEO Pursuant to Rule HTML 34K
13A-14(A)/15D-14(A)
6: EX-31.2 Certification of CFO Pursuant to Rule HTML 34K
13A-14(A)/15D-14(A)
7: EX-32.1 Certification of CEO Pursuant to 18 U.S.C. 1350 HTML 28K
8: EX-32.2 Certification of CFO Pursuant to 18 U.S.C. 1350 HTML 28K
15: R1 Document and Entity Information HTML 45K
16: R2 Condensed Consolidated Balance Sheets (Unaudited) HTML 156K
17: R3 Condensed Consolidated Balance Sheets (Unaudited) HTML 36K
(Parenthetical)
18: R4 Condensed Consolidated Statements of Earnings HTML 78K
(Unaudited)
19: R5 Condensed Consolidated Statements of Comprehensive HTML 68K
Earnings (Unaudited)
20: R6 Condensed Consolidated Statements of Comprehensive HTML 40K
Earnings (Unaudited) (Parenthetical)
21: R7 Condensed Consolidated Statements of Stockholders' HTML 62K
(Deficit) Equity (Unaudited)
22: R8 Condensed Consolidated Statements of Stockholders' HTML 29K
(Deficit) Equity (Unaudited) (Parenthetical)
23: R9 Condensed Consolidated Statements of Cash Flows HTML 112K
(Unaudited)
24: R10 Background and Basis of Presentation HTML 32K
25: R11 Asset Impairment and Exit Costs HTML 39K
26: R12 Stock Plans HTML 45K
27: R13 Benefit Plans HTML 88K
28: R14 Goodwill and Other Intangible Assets, net HTML 102K
29: R15 Financial Instruments HTML 169K
30: R16 Earnings Per Share HTML 49K
31: R17 Segment Reporting HTML 94K
32: R18 Contingencies HTML 148K
33: R19 Income Taxes HTML 35K
34: R20 Indebtedness HTML 82K
35: R21 Fair Value Measurements HTML 64K
36: R22 Accumulated Other Comprehensive Losses HTML 47K
37: R23 Balance Sheet Offsetting HTML 63K
38: R24 Investments in Unconsolidated Subsidiaries HTML 55K
39: R25 Acquisitions and Other Business Arrangements HTML 40K
40: R26 Sale of Accounts Receivable HTML 32K
41: R27 New Accounting Standards HTML 40K
42: R28 New Accounting Standards (Policies) HTML 36K
43: R29 Asset Impairment and Exit Costs (Tables) HTML 34K
44: R30 Benefit Plans (Tables) HTML 84K
45: R31 Goodwill and Other Intangible Assets, net (Tables) HTML 98K
46: R32 Financial Instruments (Tables) HTML 146K
47: R33 Earnings Per Share (Tables) HTML 47K
48: R34 Segment Reporting (Tables) HTML 88K
49: R35 Contingencies (Tables) HTML 64K
50: R36 Indebtedness (Tables) HTML 84K
51: R37 Fair Value Measurements (Tables) HTML 57K
52: R38 Accumulated Other Comprehensive Losses (Tables) HTML 42K
53: R39 Balance Sheet Offsetting (Tables) HTML 61K
54: R40 Investments in Unconsolidated Subsidiaries HTML 44K
(Tables)
55: R41 Asset Impairment and Exit Costs (Movement In The HTML 39K
Exit Cost Liabilities) (Details)
56: R42 Asset Impairment and Exit Costs (Narrative) HTML 32K
(Details)
57: R43 Stock Plans (Details) HTML 95K
58: R44 Benefit Plans (Components of Net Periodic Benefit HTML 52K
Cost) (Details)
59: R45 Benefit Plans (Narrative) (Details) HTML 32K
60: R46 Goodwill and Other Intangible Assets, net HTML 42K
(Goodwill and Other Intangible Assets, by Segment)
(Details)
61: R47 Goodwill and Other Intangible Assets, net HTML 45K
(Movement In Goodwill) (Details)
62: R48 Goodwill and Other Intangible Assets, net (Other HTML 35K
Intangible Assets) (Details)
63: R49 Goodwill and Other Intangible Assets, net (Range HTML 49K
of Useful Lives and Weighted-Average Remaining
Useful Lives of Amortizable Intangible Assets)
(Details)
64: R50 Goodwill and Other Intangible Assets, net HTML 45K
(Narrative) (Details)
65: R51 Financial Instruments (Narrative) (Details) HTML 54K
66: R52 Financial Instruments (Fair Value of Foreign HTML 51K
Exchange Contracts) (Details)
67: R53 Financial Instruments (Cash Flow and Net HTML 49K
Investment Hedging Activities Effect on Condensed
Consolidated Statements of Earnings and Other
Comprehensive Earnings) (Details)
68: R54 Financial Instruments (Qualifying Hedging Activity HTML 43K
Reported in Accumulated Other Comprehensive
Earnings (Losses) Net of Income Taxes) (Details)
69: R55 Earnings Per Share (Calculation of Basic and HTML 41K
Diluted EPS) (Details)
70: R56 Segment Reporting (Details) HTML 59K
71: R57 Contingencies (Tobacco-Related Litigation) HTML 36K
(Details)
72: R58 Contingencies (Number of Tobacco Related Cases HTML 50K
Pending Against Us and/or Our Subsidiaries or
Indemnitees) (Details)
73: R59 Contingencies (Verdicts and Post-Trial HTML 143K
Developments) (Details)
74: R60 Contingencies (Smoking And Health Litigation) HTML 251K
(Details)
75: R61 Contingencies (Health Care Cost Recovery HTML 71K
Litigation) (Details)
76: R62 Contingencies (Lights Cases) (Details) HTML 36K
77: R63 Contingencies (Public Civil Actions and Other HTML 50K
Litigation) (Details)
78: R64 Income Taxes (Details) HTML 38K
79: R65 Indebtedness (Narrative) (Details) HTML 41K
80: R66 Indebtedness (Long-Term Debt) (Details) HTML 59K
81: R67 Indebtedness (Debt Issuances During Current HTML 55K
Period) (Details)
82: R68 Indebtedness (Credit Facilities) (Details) HTML 36K
83: R69 Fair Value Measurements (Narrative) (Details) HTML 31K
84: R70 Fair Value Measurements (Aggregate Fair Value of HTML 55K
Derivative Financial Instruments, Debt and
Contingent Consideration) (Details)
85: R71 Accumulated Other Comprehensive Losses (Components HTML 43K
of Accumulated Other Comprehensive Earnings
(Losses), Net of Tax) (Details)
86: R72 Balance Sheet Offsetting (Details) HTML 72K
87: R73 Investments in Unconsolidated Subsidiaries HTML 71K
(Narrative) (Details)
88: R74 Investments in Unconsolidated Subsidiaries HTML 44K
(Balance sheet and earnings activity) (Details)
89: R75 Acquisitions and Other Business Arrangements HTML 91K
(Details)
90: R76 Sale of Accounts Receivable (Details) HTML 30K
92: XML IDEA XML File -- Filing Summary XML 170K
91: EXCEL IDEA Workbook of Financial Reports XLSX 97K
9: EX-101.INS XBRL Instance -- pm-20160630 XML 2.67M
11: EX-101.CAL XBRL Calculations -- pm-20160630_cal XML 223K
12: EX-101.DEF XBRL Definitions -- pm-20160630_def XML 772K
13: EX-101.LAB XBRL Labels -- pm-20160630_lab XML 1.76M
14: EX-101.PRE XBRL Presentations -- pm-20160630_pre XML 1.06M
10: EX-101.SCH XBRL Schema -- pm-20160630 XSD 209K
93: ZIP XBRL Zipped Folder -- 0001413329-16-000096-xbrl Zip 260K
| Exhibit |
 | PricewaterhouseCoopers SA | |
Avenue C.-F - Ramuz 45 | ||
Case Postale 1172 | ||
1001
Lausanne | ||
Telephone: +41 58 792 81 00 | ||
Facsimile: +41 58 792 81 10 | ||
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 7/26/16 | |||
| For Period end: | 6/30/16 | 4 | ||
| 12/31/15 | 10-K, 11-K, 4 | |||
| List all Filings | ||||